News Opinion Editor's Corner TCT 2017 Live From Denver: TCT 2017, Day Four Shelley Wood November 02, 2017
News Daily News Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device Todd Neale October 12, 2017
News Daily News Stroke, Bleeding Risks High in A-fib Patients With Contraindications to Anticoagulation Todd Neale September 27, 2017
News Daily News Many Stroke Patients Stop Statins or Never Start, With Dire Consequences Michael O'Riordan August 02, 2017
Presentation LAA 2017 Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure? Presenter: Vivek Y. Reddy July 21, 2017
News Daily News ‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry Todd Neale May 17, 2017
News Daily News MR CLEAN: Sustained Benefit of Endovascular Therapy for Acute Ischemic Stroke Michael O'Riordan April 05, 2017
Presentation SIF 2017 Thromboembolic Prophylaxis in Atrial Fibrillation Presenter: Samir Kapadia March 09, 2017
News Conference News ISC 2017 NOAC-Related Intracranial Hemorrhages May Not Be as Bad as Those Stemming From Warfarin Todd Neale March 01, 2017
News Conference News AHA 2016 Misdosing NOACs Common in Everyday Practice, With Implications for Stroke and Bleeding Shelley Wood November 21, 2016
News Conference News AHA 2016 Errar la Dosis de NOAC en la Práctica Clínica Diaria es algo Habitual, lo cual tiene Implicaciones en Materia de ACV y Hemorragias Shelley Wood November 21, 2016
News Daily News FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm Michael O'Riordan October 11, 2016
News Daily News Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation Michael O'Riordan October 07, 2016
News Daily News Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns Shelley Wood September 13, 2016
News Industry News St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation September 01, 2016
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016